These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Thrombopoietin levels in systemic lupus erythematosus are linked to inflammatory cytokines, but unrelated to thrombocytopenia or thrombosis. Lu C; Nossent J Lupus; 2015 Jan; 24(1):18-24. PubMed ID: 25117655 [TBL] [Abstract][Full Text] [Related]
3. MECHANISMS OF THROMBOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS. Metoni A; Mambet C; Necula LG; Aldea IM; Neagu AI; Matei L; Dragu D; Bleotu C; Ion DA; Diaconu CC Roum Arch Microbiol Immunol; 2014; 73(3-4):92-8. PubMed ID: 26201124 [TBL] [Abstract][Full Text] [Related]
5. Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphospholipid antibodies. Horbach DA; van Oort E; Donders RC; Derksen RH; de Groot PG Thromb Haemost; 1996 Dec; 76(6):916-24. PubMed ID: 8972011 [TBL] [Abstract][Full Text] [Related]
7. Superficial vein thrombosis, thrombin generation and activated protein C resistance as predictors of thromboembolic events in lupus and antiphospholipid patients. A prospective cohort study. Zuily S; Regnault V; Guillemin F; Kaminsky P; Rat AC; Lecompte T; Wahl D Thromb Res; 2013 Jul; 132(1):e1-7. PubMed ID: 23676348 [TBL] [Abstract][Full Text] [Related]
8. Characterization of the thrombin generation profile in systemic lupus erythematosus. Kern A; Barabás E; Balog A; Burcsár S; Kiszelák M; Vásárhelyi B Physiol Int; 2017 Mar; 104(1):35-41. PubMed ID: 28361572 [TBL] [Abstract][Full Text] [Related]
9. In systemic lupus erythematosus anti-dsDNA antibodies can promote thrombosis through direct platelet activation. Andrianova IA; Ponomareva AA; Mordakhanova ER; Le Minh G; Daminova AG; Nevzorova TA; Rauova L; Litvinov RI; Weisel JW J Autoimmun; 2020 Feb; 107():102355. PubMed ID: 31732191 [TBL] [Abstract][Full Text] [Related]
10. Association of lupus anticoagulant and anticardiolipin antibodies with thrombosis in patients with systemic lupus erythematosus, primary antiphospholipid syndrome and other disorders. Brenner B; Tavori S; Lerner M; Tatarsky I; Lorber M Isr J Med Sci; 1992 Jan; 28(1):9-15. PubMed ID: 1733904 [TBL] [Abstract][Full Text] [Related]
12. The relationship of antiphospholipid antibodies to thromboembolic events in pediatric patients with systemic lupus erythematosus: a cross-sectional study. Berube C; Mitchell L; Silverman E; David M; Saint Cyr C; Laxer R; Adams M; Vegh P; Andrew M Pediatr Res; 1998 Sep; 44(3):351-6. PubMed ID: 9727712 [TBL] [Abstract][Full Text] [Related]
13. Increased C1q, C4 and C3 deposition on platelets in patients with systemic lupus erythematosus--a possible link to venous thrombosis? Lood C; Eriksson S; Gullstrand B; Jönsen A; Sturfelt G; Truedsson L; Bengtsson AA Lupus; 2012 Nov; 21(13):1423-32. PubMed ID: 22878256 [TBL] [Abstract][Full Text] [Related]
14. Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies. Tektonidou MG; Laskari K; Panagiotakos DB; Moutsopoulos HM Arthritis Rheum; 2009 Jan; 61(1):29-36. PubMed ID: 19116963 [TBL] [Abstract][Full Text] [Related]
16. Peripheral arterial thrombosis in systemic lupus erythematosis and nephrotic syndrome: possible association with protein S deficiency. Beşbaş N; Doğru D; Bakkaloğlu A; Ozen S; Balkanci F; Saatçi U Turk J Pediatr; 1997; 39(1):143-7. PubMed ID: 10868207 [TBL] [Abstract][Full Text] [Related]
17. More about the link between thrombosis and atherosclerosis in autoimmune diseases: triglycerides and risk for thrombosis in patients with antiphospholipid antibodies. Garrido JA; Peromingo JA; Sesma P; Pia G J Rheumatol; 1994 Dec; 21(12):2394. PubMed ID: 7699654 [No Abstract] [Full Text] [Related]
18. Transiently positive anticardiolipin antibodies and risk of thrombosis in patients with systemic lupus erythematosus. Martinez-Berriotxoa A; Ruiz-Irastorza G; Egurbide MV; Garmendia M; Gabriel Erdozain J; Villar I; Aguirre C Lupus; 2007; 16(10):810-6. PubMed ID: 17895304 [TBL] [Abstract][Full Text] [Related]
19. Thrombotic risk assessment in systemic lupus erythematosus: validation of the global antiphospholipid syndrome score in a prospective cohort. Sciascia S; Cuadrado MJ; Sanna G; Murru V; Roccatello D; Khamashta MA; Bertolaccini ML Arthritis Care Res (Hoboken); 2014 Dec; 66(12):1915-20. PubMed ID: 24964745 [TBL] [Abstract][Full Text] [Related]